Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Global Gamma Knife Market Research Report: Information By Disease Indication (Brain Metastasis, Cancer, Arteriovenous Malformation, Trigeminal Neuralgia, Others), By Anatomy (Head, Neck, Others) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032


ID: MRFR/HC/17643-HCR | 128 Pages | Author: Rahul Gotadki| June 2024

Market Segmentation


Gamma Knife Disease Indication Outlook (USD Billion, 2018-2032)



  • Brain Metastasis

  • Cancer

  • Arteriovenous Malformation

  • Trigeminal Neuralgia

  • Others


Gamma Knife Anatomy Outlook (USD Billion, 2018-2032)



  • Head

  • Neck

  • Others


Gamma Knife Regional Outlook (USD Billion, 2018-2032)




  • North America Outlook (USD Billion, 2018-2032)


    • North America Gamma Knife by Disease Indication

      • Brain Metastasis

      • Cancer

      • Arteriovenous Malformation

      • Trigeminal Neuralgia

      • Others




    • North America Gamma Knife by Anatomy

      • Head

      • Neck

      • Others




    • US Outlook (USD Billion, 2018-2032)


    • US Gamma Knife by Disease Indication

      • Brain Metastasis

      • Cancer

      • Arteriovenous Malformation

      • Trigeminal Neuralgia

      • Others




    • US Gamma Knife by Anatomy

      • Head

      • Neck

      • Others




    • CANADA Outlook (USD Billion, 2018-2032)


    • CANADA Gamma Knife by Disease Indication

      • Brain Metastasis

      • Cancer

      • Arteriovenous Malformation

      • Trigeminal Neuralgia

      • Others




    • CANADA Gamma Knife by Anatomy

      • Head

      • Neck

      • Others




    • Europe Outlook (USD Billion, 2018-2032)


      • Europe Gamma Knife by Disease Indication

        • Brain Metastasis

        • Cancer

        • Arteriovenous Malformation

        • Trigeminal Neuralgia

        • Others




      • Europe Gamma Knife by Anatomy

        • Head

        • Neck

        • Others




      • Germany Outlook (USD Billion, 2018-2032)


      • Germany Gamma Knife by Disease Indication

        • Brain Metastasis

        • Cancer

        • Arteriovenous Malformation

        • Trigeminal Neuralgia

        • Others




      • Germany Gamma Knife by Anatomy

        • Head

        • Neck

        • Others



      • France Outlook (USD Billion, 2018-2032)


      • France Gamma Knife by Disease Indication

        • Brain Metastasis

        • Cancer

        • Arteriovenous Malformation

        • Trigeminal Neuralgia

        • Others




      • France Gamma Knife by Anatomy

        • Head

        • Neck

        • Others




      • UK Outlook (USD Billion, 2018-2032)


      • UK Gamma Knife by Disease Indication

        • Brain Metastasis

        • Cancer

        • Arteriovenous Malformation

        • Trigeminal Neuralgia

        • Others




      • UK Gamma Knife by Anatomy

        • Head

        • Neck

        • Others




      • ITALY Outlook (USD Billion, 2018-2032)


      • ITALY Gamma Knife by Disease Indication

        • Brain Metastasis

        • Cancer

        • Arteriovenous Malformation

        • Trigeminal Neuralgia

        • Others




      • ITALY Gamma Knife by Anatomy

        • Head

        • Neck

        • Others




      • SPAIN Outlook (USD Billion, 2018-2032)


      • Spain Gamma Knife by Disease Indication

        • Brain Metastasis

        • Cancer

        • Arteriovenous Malformation

        • Trigeminal Neuralgia

        • Others




      • Spain Gamma Knife by Anatomy

        • Head

        • Neck

        • Others




      • Rest Of Europe Outlook (USD Billion, 2018-2032)


      • Rest Of Europe Gamma Knife by Disease Indication

        • Brain Metastasis

        • Cancer

        • Arteriovenous Malformation

        • Trigeminal Neuralgia

        • Others




      • REST OF EUROPE Gamma Knife by Anatomy

        • Head

        • Neck

        • Others




      • Asia-Pacific Outlook (USD Billion, 2018-2032)


        • Asia-Pacific Gamma Knife by Disease Indication

          • Brain Metastasis

          • Cancer

          • Arteriovenous Malformation

          • Trigeminal Neuralgia

          • Others




        • Asia-Pacific Gamma Knife by Anatomy

          • Head

          • Neck

          • Others




        • China Outlook (USD Billion, 2018-2032)


        • China Gamma Knife by Disease Indication

          • Brain Metastasis

          • Cancer

          • Arteriovenous Malformation

          • Trigeminal Neuralgia

          • Others




        • China Gamma Knife by Anatomy

          • Head

          • Neck

          • Others




        • Japan Outlook (USD Billion, 2018-2032)


        • Japan Gamma Knife by Disease Indication

          • Brain Metastasis

          • Cancer

          • Arteriovenous Malformation

          • Trigeminal Neuralgia

          • Others




        • Japan Gamma Knife by Anatomy

          • Head

          • Neck

          • Others




        • India Outlook (USD Billion, 2018-2032)


        • India Gamma Knife by Disease Indication

          • Brain Metastasis

          • Cancer

          • Arteriovenous Malformation

          • Trigeminal Neuralgia

          • Others




        • India Gamma Knife by Anatomy

          • Head

          • Neck

          • Others




        • Australia Outlook (USD Billion, 2018-2032)


        • Australia Gamma Knife by Disease Indication

          • Brain Metastasis

          • Cancer

          • Arteriovenous Malformation

          • Trigeminal Neuralgia

          • Others




        • Australia Gamma Knife by Anatomy

          • Head

          • Neck

          • Others




        • Rest of Asia-Pacific Outlook (USD Billion, 2018-2032)


        • Rest of Asia-Pacific Gamma Knife by Disease Indication

          • Brain Metastasis

          • Cancer

          • Arteriovenous Malformation

          • Trigeminal Neuralgia

          • Others




        • Rest of Asia-Pacific Gamma Knife by Anatomy

          • Head

          • Neck

          • Others




        • Rest of the World Outlook (USD Billion, 2018-2032)


          • Rest of the World Gamma Knife by Disease Indication

            • Brain Metastasis

            • Cancer

            • Arteriovenous Malformation

            • Trigeminal Neuralgia

            • Others




          • Rest of the World Gamma Knife by Anatomy

            • Head

            • Neck

            • Others




          • Middle East Outlook (USD Billion, 2018-2032)


          • Middle East Gamma Knife by Disease Indication

            • Brain Metastasis

            • Cancer

            • Arteriovenous Malformation

            • Trigeminal Neuralgia

            • Others




          • Middle East Gamma Knife by Anatomy

            • Head

            • Neck

            • Others




          • Africa Outlook (USD Billion, 2018-2032)


          • Africa Gamma Knife by Disease Indication

            • Brain Metastasis

            • Cancer

            • Arteriovenous Malformation

            • Trigeminal Neuralgia

            • Others




          • Africa Gamma Knife by Anatomy

            • Head

            • Neck

            • Others




          • Latin America Outlook (USD Billion, 2018-2032)


          • Latin America Gamma Knife by Disease Indication

            • Brain Metastasis

            • Cancer

            • Arteriovenous Malformation

            • Trigeminal Neuralgia

            • Others




          • Latin America Gamma Knife by Anatomy

            • Head

            • Neck

            • Others











Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Model

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Value Chain Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. GLOBAL GAMMA KNIFE MARKET, BY DISEASE INDICATION

6.1. Overview

6.2. Brain Metastasis

6.3. Cancer

6.4. Arteriovenous Malformation

6.5. Trigeminal Neuralgia

6.6. Others

7. GLOBAL GAMMA KNIFE MARKET, BY ANATOMY

7.1. Overview

7.2. Head

7.3. Neck

7.4. Other

8. GLOBAL GAMMA KNIFE MARKET, BY REGION

8.1. Overview

8.1. North America

8.1.1. US

8.1.2. Canada

8.2. Europe

8.2.1. Germany

8.2.2. France

8.2.3. UK

8.2.4. Italy

8.2.5. Spain

8.2.6. Rest of Europe

8.3. Asia-Pacific

8.3.1. China

8.3.2. India

8.3.3. Japan

8.3.4. South Korea

8.3.5. Australia

8.3.6. Rest of Asia-Pacific

8.4. Rest of the World

8.4.1. Middle East

8.4.2. Africa

8.4.3. Latin America

9. COMPETITIVE LANDSCAPE

9.1. Overview

9.2. Competitive Analysis

9.3. Market Share Analysis

9.4. Major Growth Strategy in the Global Gamma knife Market,

9.5. Competitive Benchmarking

9.6. Leading Players in Terms of Number of Developments in the Global Gamma knife Market,

9.7. Key developments and Growth Strategies

9.7.1. New Anatomy Launch/Service Deployment

9.7.2. Merger & Acquisitions

9.7.3. Joint Ventures

9.8. Major Players Financial Matrix

9.8.1. Sales & Operating Income, 2022

9.8.2. Major Players R&D Expenditure. 2022

10. COMPANY PROFILES

10.1. ELEKTA

10.1.1. Company Overview

10.1.2. Financial Overview

10.1.3. Anatomys Offered

10.1.4. Key Developments

10.1.5. SWOT Analysis

10.1.6. Key Strategies

10.2. VARIAN MEDICAL SYSTEMS

10.2.1. Company Overview

10.2.2. Financial Overview

10.2.3. Anatomys Offered

10.2.4. Key Developments

10.2.5. SWOT Analysis

10.2.6. Key Strategies

10.3. HUIHENG MEDICAL, INC.

10.3.1. Company Overview

10.3.2. Financial Overview

10.3.3. Anatomys Offered

10.3.4. Key Developments

10.3.5. SWOT Analysis

10.3.6. Key Strategies

10.4. AKESIS, INC

10.4.1. Company Overview

10.4.2. Financial Overview

10.4.3. Anatomys Offered

10.4.4. Key Developments

10.4.5. SWOT Analysis

10.4.6. Key Strategies

10.5. MASEP MEDICAL SCIENCE TECHNOLOGY DEVELOPMENT (SHENZHEN) CO., LTD.

10.5.1. Company Overview

10.5.2. Financial Overview

10.5.3. Anatomys Offered

10.5.4. Key Developments

10.5.5. SWOT Analysis

10.5.6. Key Strategies

10.6. AMERICAN RADIOSURGERY INC.

10.6.1. Company Overview

10.6.2. Financial Overview

10.6.3. Anatomys Offered

10.6.4. Key Developments

10.6.5. SWOT Analysis

10.6.6. Key Strategies

10.7. PANACEA MEDICAL TECHNOLOGIES PVT. LTD.

10.7.1. Company Overview

10.7.2. Financial Overview

10.7.3. Anatomys Offered

10.7.4. Key Developments

10.7.5. SWOT Analysis

10.7.6. Key Strategies

10.8. Nordion (Canada) Inc.

10.8.1. Company Overview

10.8.2. Financial Overview

10.8.3. Anatomys Offered

10.8.4. Key Developments

10.8.5. SWOT Analysis

10.8.6. Key Strategies

10.9. Accuray Incorporated

10.9.1. Company Overview

10.9.2. Financial Overview

10.9.3. Anatomys Offered

10.9.4. Key Developments

10.9.5. SWOT Analysis

10.9.6. Key Strategies

10.10. Hitachi, Ltd.

10.10.1. Company Overview

10.10.2. Financial Overview

10.10.3. Anatomys Offered

10.10.4. Key Developments

10.10.5. SWOT Analysis

10.10.6. Key Strategies

11. APPENDIX

11.1. References

11.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL GAMMA KNIFE MARKET, SYNOPSIS, 2018-2032

TABLE 2 GLOBAL GAMMA KNIFE MARKET, ESTIMATES & FORECAST, 2018-2032 (USD BILLION)

TABLE 3 GLOBAL GAMMA KNIFE MARKET, BY DISEASE INDICATION, 2018-2032 (USD BILLION)

TABLE 4 GLOBAL GAMMA KNIFE MARKET, BY ANATOMY, 2018-2032 (USD BILLION)

TABLE 5 NORTH AMERICA: GAMMA KNIFE MARKET, BY DISEASE INDICATION, 2018-2032 (USD BILLION)

TABLE 6 NORTH AMERICA: GAMMA KNIFE MARKET, BY ANATOMY, 2018-2032 (USD BILLION)

TABLE 7 US: GAMMA KNIFE MARKET, BY DISEASE INDICATION, 2018-2032 (USD BILLION)

TABLE 8 US: GAMMA KNIFE MARKET, BY ANATOMY, 2018-2032 (USD BILLION)

TABLE 9 CANADA: GAMMA KNIFE MARKET, BY DISEASE INDICATION, 2018-2032 (USD BILLION)

TABLE 10 CANADA: GAMMA KNIFE MARKET, BY ANATOMY, 2018-2032 (USD BILLION)

TABLE 1 EUROPE: GAMMA KNIFE MARKET, BY DISEASE INDICATION, 2018-2032 (USD BILLION)

TABLE 2 EUROPE: GAMMA KNIFE MARKET, BY ANATOMY, 2018-2032 (USD BILLION)

TABLE 3 GERMANY: GAMMA KNIFE MARKET, BY DISEASE INDICATION, 2018-2032 (USD BILLION)

TABLE 4 GERMANY: GAMMA KNIFE MARKET, BY ANATOMY, 2018-2032 (USD BILLION)

TABLE 5 FRANCE: GAMMA KNIFE MARKET, BY DISEASE INDICATION, 2018-2032 (USD BILLION)

TABLE 6 FRANCE: GAMMA KNIFE MARKET, BY ANATOMY, 2018-2032 (USD BILLION)

TABLE 7 ITALY: GAMMA KNIFE MARKET, BY DISEASE INDICATION, 2018-2032 (USD BILLION)

TABLE 8 ITALY: GAMMA KNIFE MARKET, BY ANATOMY, 2018-2032 (USD BILLION)

TABLE 9 SPAIN: GAMMA KNIFE MARKET, BY DISEASE INDICATION, 2018-2032 (USD BILLION)

TABLE 10 SPAIN: GAMMA KNIFE MARKET, BY ANATOMY, 2018-2032 (USD BILLION)

TABLE 11 UK: GAMMA KNIFE MARKET, BY DISEASE INDICATION, 2018-2032 (USD BILLION)

TABLE 12 UK: GAMMA KNIFE MARKET, BY ANATOMY, 2018-2032 (USD BILLION)

TABLE 13 REST OF EUROPE: GAMMA KNIFE MARKET, BY DISEASE INDICATION, 2018-2032 (USD BILLION)

TABLE 14 REST OF EUROPE: GAMMA KNIFE MARKET, BY ANATOMY, 2018-2032 (USD BILLION)

TABLE 15 ASIA-PACIFIC: GAMMA KNIFE MARKET, BY DISEASE INDICATION, 2018-2032 (USD BILLION)

TABLE 16 ASIA-PACIFIC: GAMMA KNIFE MARKET, BY ANATOMY, 2018-2032 (USD BILLION)

TABLE 17 JAPAN: GAMMA KNIFE MARKET, BY DISEASE INDICATION, 2018-2032 (USD BILLION)

TABLE 18 JAPAN: GAMMA KNIFE MARKET, BY ANATOMY, 2018-2032 (USD BILLION)

TABLE 19 CHINA: GAMMA KNIFE MARKET, BY DISEASE INDICATION, 2018-2032 (USD BILLION)

TABLE 20 CHINA: GAMMA KNIFE MARKET, BY ANATOMY, 2018-2032 (USD BILLION)

TABLE 21 INDIA: GAMMA KNIFE MARKET, BY DISEASE INDICATION, 2018-2032 (USD BILLION)

TABLE 22 INDIA: GAMMA KNIFE MARKET, BY ANATOMY, 2018-2032 (USD BILLION)

TABLE 23 AUSTRALIA: GAMMA KNIFE MARKET, BY DISEASE INDICATION, 2018-2032 (USD BILLION)

TABLE 24 AUSTRALIA: GAMMA KNIFE MARKET, BY ANATOMY, 2018-2032 (USD BILLION)

TABLE 25 SOUTH KOREA: GAMMA KNIFE MARKET, BY DISEASE INDICATION, 2018-2032 (USD BILLION)

TABLE 26 SOUTH KOREA: GAMMA KNIFE MARKET, BY ANATOMY, 2018-2032 (USD BILLION)

TABLE 27 REST OF ASIA-PACIFIC: GAMMA KNIFE MARKET, BY DISEASE INDICATION, 2018-2032 (USD BILLION)

TABLE 28 REST OF ASIA-PACIFIC: GAMMA KNIFE MARKET, BY ANATOMY, 2018-2032 (USD BILLION)

TABLE 29 REST OF THE WORLD: GAMMA KNIFE MARKET, BY DISEASE INDICATION, 2018-2032 (USD BILLION)

TABLE 30 REST OF THE WORLD: GAMMA KNIFE MARKET, BY ANATOMY, 2018-2032 (USD BILLION)

TABLE 31 MIDDLE EAST: GAMMA KNIFE MARKET, BY DISEASE INDICATION, 2018-2032 (USD BILLION)

TABLE 32 MIDDLE EAST: GAMMA KNIFE MARKET, BY ANATOMY, 2018-2032 (USD BILLION)

TABLE 33 AFRICA: GAMMA KNIFE MARKET, BY DISEASE INDICATION, 2018-2032 (USD BILLION)

TABLE 34 AFRICA: GAMMA KNIFE MARKET, BY ANATOMY, 2018-2032 (USD BILLION)

TABLE 35 LATIN AMERICA: GAMMA KNIFE MARKET, BY DISEASE INDICATION, 2018-2032 (USD BILLION)

TABLE 36 LATIN AMERICA: GAMMA KNIFE MARKET, BY ANATOMY, 2018-2032 (USD BILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL GAMMA KNIFE MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL GAMMA KNIFE MARKET

FIGURE 4 GLOBAL GAMMA KNIFE MARKET, SHARE (%), BY DISEASE INDICATION, 2022

FIGURE 5 GLOBAL GAMMA KNIFE MARKET, SHARE (%), BY ANATOMY, 2022

FIGURE 6 GLOBAL GAMMA KNIFE MARKET, SHARE (%), BY REGION, 2022

FIGURE 7 NORTH AMERICA: GAMMA KNIFE MARKET, SHARE (%), BY REGION, 2022

FIGURE 8 EUROPE: GAMMA KNIFE MARKET, SHARE (%), BY REGION, 2022

FIGURE 9 ASIA-PACIFIC: GAMMA KNIFE MARKET, SHARE (%), BY REGION, 2022

FIGURE 10 REST OF THE WORLD: GAMMA KNIFE MARKET, SHARE (%), BY REGION, 2022

FIGURE 11 GLOBAL GAMMA KNIFE MARKET: COMPANY SHARE ANALYSIS, 2022 (%)

FIGURE 12 ELEKTA: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 13 ELEKTA: SWOT ANALYSIS

FIGURE 14 VARIAN MEDICAL SYSTEMS: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 15 VARIAN MEDICAL SYSTEMS: SWOT ANALYSIS

FIGURE 16 HUIHENG MEDICAL, INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 17 HUIHENG MEDICAL, INC.: SWOT ANALYSIS

FIGURE 18 AKESIS, INC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 19 AKESIS, INC: SWOT ANALYSIS

FIGURE 20 MASEP MEDICAL SCIENCE TECHNOLOGY DEVELOPMENT (SHENZHEN) CO., LTD..: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 21 MASEP MEDICAL SCIENCE TECHNOLOGY DEVELOPMENT (SHENZHEN) CO., LTD..: SWOT ANALYSIS

FIGURE 22 AMERICAN RADIOSURGERY INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 23 AMERICAN RADIOSURGERY INC.: SWOT ANALYSIS

FIGURE 24 PANACEA MEDICAL TECHNOLOGIES PVT. LTD.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 25 PANACEA MEDICAL TECHNOLOGIES PVT. LTD.: SWOT ANALYSIS

FIGURE 26 NORDION (CANADA) INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 27 NORDION (CANADA) INC.: SWOT ANALYSIS

FIGURE 28 ACCURAY INCORPORATED: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 29 ACCURAY INCORPORATED: SWOT ANALYSIS

FIGURE 30 HITACHI, LTD.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 31 HITACHI, LTD.: SWOT ANALYSIS

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.